Illumina Inc Revenue per Employee (ILMN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Illumina Inc   (NASDAQ: ILMN)
 

Illumina Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 4.15% in the third quarter 2026, year on year to cumulative value of $4,538 million, Illumina Inc 's revenue per employee grew on a trailing twelve months basis to $ 3,545,313. The productivity of Illumina Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 16 other companies have achieved higher revenue per employee. While Illumina Inc 's total ranking has deteriorated compared to the previous quarter from 91 to 264. Illumina Inc has 1,280 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ILMN Revenue per Employee (Sep 27 2026)
III. Quarter		 (Jun 28 2026)
II. Quarter		 (Mar 29 2026)
I. Quarter		 (Dec 28 2025)
IV. Quarter		 (Sep 28 2025)
III. Quarter
Y / Y Revenue Change 4.15 % 9.44 % 4.8 % 4.98 % 0.37 %
Sales per Employee (TTM) $ 3,545,313 3,510,156 3,432,031 3,392,969 3,350,000
ILMN's Total Ranking # 264 # 91 # 409 # 451 #
Seq. Revenue Change -2.59 % 6.23 % -5.87 % 6.92 % 2.36 %

ILMN Company Profile >> Back to ILMN Efficiency Comparisons >> Compare ILMN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 1
Healthcare Sector # 17
Overall Market # 264

Revenue per Employee Statistics
High Average Low
$ 3,671,094 $ 2,658,608 $ 1,215,691
(Oct 02 2022)   (March 31, 2014)



Financial Statements
Illumina Inc 's Revenue MRQ $ 1,129 Millions Visit ILMN's Income Statement
Illumina Inc 's Revenues TTM $ 4,538 Millions Visit ILMN's aggregate revenue growth
What are ILMN's Sales? Visit ILMN's Sales by Segment




Other Ratios
Illumina Inc 's Income per Employee
Employees in Laboratory Analytical Instruments
Laboratory Analytical Instruments Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ILMN's Revenue per Employee versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ILMN's Competitors
Revenue per Employee for ILMN's Suppliers
Revenue per Employee for ILMN's Customers

You may also want to know
ILMN's Sales Growth Rates ILMN's Pe Price to earnings ratio ILMN's Receivables Turnover Ratio ILMN's Stock Quote
ILMN's Net Income Growth Rates ILMN's Ps Price to Sales ratio ILMN's Sales per Employee ILMN's Asset Turnover Ratio
ILMN's Net Margin ILMN's Pb Price to Book ratio ILMN's Financial Strength Ratios ILMN's Dividend Payout Ratio
Date modified: 2026-10-31T09:55:44+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 27 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 27 2026Number of Employees Sep 27 2026
Ligand Pharmaceuticals Incorporated  5,400,574.47 $ 253.827  Million 47 
Halozyme Therapeutics Inc   4,261,106.38 $ 1,802.448  Million 423 
Ironwood Pharmaceuticals inc   4,002,960.00 $ 400.296  Million 100 
Community Health Systems Inc   3,759,032.26 $ 11,653.000  Million 3,100 
Illumina Inc   3,545,312.50 $ 4,538.000  Million 1,280 
Kiniksa Pharmaceuticals International Plc  2,584,598.36 $ 945.963  Million 366 
Aurinia Pharmaceuticals Inc   2,513,578.12 $ 321.738  Million 128 
Sarepta Therapeutics Inc   2,342,920.96 $ 1,956.339  Million 835 
Zevra Therapeutics Inc   2,304,065.57 $ 140.548  Million 61 
Nurix Therapeutics Inc   2,214,309.15 $ 701.936  Million 317 
Exelixis Inc   2,176,862.25 $ 2,496.861  Million 1,147 
Incyte Corporation  2,113,485.94 $ 6,010.754  Million 2,844 
Alnylam Pharmaceuticals Inc   2,005,296.80 $ 5,013.242  Million 2,500 
Neurocrine Biosciences Inc   1,850,850.00 $ 3,701.700  Million 2,000 
Tarsus Pharmaceuticals Inc   1,843,791.89 $ 682.203  Million 370 
Gilead Sciences Inc   1,822,823.53 $ 30,988.000  Million 17,000 
Mirum Pharmaceuticals Inc   1,803,166.67 $ 670.778  Million 372 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.